Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 2
1947 2
1948 2
1950 1
1951 2
1952 1
1954 1
1955 5
1956 3
1957 4
1958 4
1959 2
1960 2
1961 3
1962 2
1963 2
1964 4
1965 1
1966 3
1967 10
1968 5
1969 5
1970 6
1971 12
1972 6
1973 3
1974 7
1975 5
1976 21
1977 13
1978 15
1979 15
1980 20
1981 26
1982 25
1983 24
1984 18
1985 21
1986 19
1987 43
1988 31
1989 31
1990 39
1991 41
1992 32
1993 42
1994 37
1995 49
1996 45
1997 48
1998 70
1999 54
2000 80
2001 84
2002 87
2003 86
2004 85
2005 99
2006 116
2007 102
2008 119
2009 124
2010 128
2011 133
2012 142
2013 140
2014 166
2015 190
2016 194
2017 211
2018 234
2019 214
2020 233
2021 284
2022 243
2023 228
2024 272

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,444 results

Results by year

Filters applied: . Clear all
Page 1
Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments.
Maronese CA, Pimentel MA, Li MM, Genovese G, Ortega-Loayza AG, Marzano AV. Maronese CA, et al. Am J Clin Dermatol. 2022 Sep;23(5):615-634. doi: 10.1007/s40257-022-00699-8. Epub 2022 May 24. Am J Clin Dermatol. 2022. PMID: 35606650 Free PMC article. Review.
Low-evidence studies and a lack of validated diagnostic and response criteria have hindered the discovery and validation of new effective treatments for pyoderma gangrenosum. We review established and emerging treatments for pyoderma gangrenosum. ...Fo …
Low-evidence studies and a lack of validated diagnostic and response criteria have hindered the discovery and validation of new effective tr …
Pyoderma Gangrenosum: A Literature Review.
Barbe M, Batra A, Golding S, Hammond O, Higgins JC, O'Connor A, Vlahovic TC. Barbe M, et al. Clin Podiatr Med Surg. 2021 Oct;38(4):577-588. doi: 10.1016/j.cpm.2021.06.002. Clin Podiatr Med Surg. 2021. PMID: 34538436 Review.
Pyoderma gangrenosum (PG), which most frequently affects the lower extremity, is a complicated disease state that results from a combination of inflammation, neutrophilic invasion, and genetic predisposition. ...
Pyoderma gangrenosum (PG), which most frequently affects the lower extremity, is a complicated disease state that results from …
Pyoderma gangrenosum.
Maverakis E, Marzano AV, Le ST, Callen JP, Brüggen MC, Guenova E, Dissemond J, Shinkai K, Langan SM. Maverakis E, et al. Nat Rev Dis Primers. 2020 Oct 8;6(1):81. doi: 10.1038/s41572-020-0213-x. Nat Rev Dis Primers. 2020. PMID: 33033263 Review.
Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis that presents with rapidly developing, painful skin ulcers hallmarked by undermined borders and peripheral erythema. ...
Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis that presents with rapidly developing, painful skin ulcers hallmar …
Pyoderma Gangrenosum.
Hou YL, Lee CH. Hou YL, et al. JAMA Dermatol. 2022 Feb 1;158(2):202. doi: 10.1001/jamadermatol.2021.5001. JAMA Dermatol. 2022. PMID: 34910081 No abstract available.
Pyoderma gangrenosum.
Yeung KCY, O'Connor EM, Hull PR. Yeung KCY, et al. BMJ. 2023 Sep 6;382:e075863. doi: 10.1136/bmj-2023-075863. BMJ. 2023. PMID: 37673429 No abstract available.
[Pyoderma gangrenosum].
Burian EA, Karlsmark T, Fogh K, Bech R. Burian EA, et al. Ugeskr Laeger. 2021 Jun 14;183(24):V12200949. Ugeskr Laeger. 2021. PMID: 34120685 Free article. Review. Danish.
Pyoderma gangrenosum is a diagnostic and therapeutic challenge. A misdiagnosis or delayed diagnosis can lead to increased morbidity and death. ...
Pyoderma gangrenosum is a diagnostic and therapeutic challenge. A misdiagnosis or delayed diagnosis can lead to increased morb …
Treatment of Pyoderma Gangrenosum.
Tan MG, Tolkachjov SN. Tan MG, et al. Dermatol Clin. 2024 Apr;42(2):183-192. doi: 10.1016/j.det.2023.12.002. Epub 2023 Dec 29. Dermatol Clin. 2024. PMID: 38423680 Review.
Pyoderma gangrenosum is a rare neutrophilic dermatosis that results in painful cutaneous ulcers and is frequently associated with underlying hematologic disorders, inflammatory bowel disease, or other autoimmune disorders. ...
Pyoderma gangrenosum is a rare neutrophilic dermatosis that results in painful cutaneous ulcers and is frequently associated w …
Pyoderma gangrenosum.
Mehrtens SH, Crawley JM. Mehrtens SH, et al. Br J Hosp Med (Lond). 2015 Nov;76(11):C173-6. doi: 10.12968/hmed.2015.76.11.C173. Br J Hosp Med (Lond). 2015. PMID: 26551510 Review. No abstract available.
Pyoderma Gangrenosum: An Update on Pathophysiology, Diagnosis and Treatment.
Alavi A, French LE, Davis MD, Brassard A, Kirsner RS. Alavi A, et al. Am J Clin Dermatol. 2017 Jun;18(3):355-372. doi: 10.1007/s40257-017-0251-7. Am J Clin Dermatol. 2017. PMID: 28224502 Review.
Pyoderma gangrenosum (PG) is a rare inflammatory neutrophilic disorder with prototypical clinical presentations. ...
Pyoderma gangrenosum (PG) is a rare inflammatory neutrophilic disorder with prototypical clinical presentations. ...
Pyoderma gangrenosum.
[No authors listed] [No authors listed] Nat Rev Dis Primers. 2020 Oct 8;6(1):80. doi: 10.1038/s41572-020-00221-6. Nat Rev Dis Primers. 2020. PMID: 33033257 No abstract available.
4,444 results